FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Lehrstuhl für Klinische und Molekulare Virologie
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Institute of Clinical and Molecular Virology
Overview
Publications
(407)
Research Grants
(5)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Iota-carrageenan inhibits replication of sars-cov-2 and the respective variants of concern alpha, beta, gamma and delta (2021)
Fröba M, Große M, Setz C, Rauch P, Auth J, Spanaus L, Münch J, et al.
Journal article
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization (2021)
Lapuente D, Fuchs J, Willar J, Vieira Antao AI, Eberlein V, Uhlig N, Issmail L, et al.
Journal article
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections (2021)
Bénard A, Jacobsen A, Brunner M, Krautz C, Klösch B, Swierzy I, Naschberger E, et al.
Journal article
Is the BNT162b2 COVID-19 vaccine effective in elderly populations? Results from population data from Bavaria, Germany (2021)
Gomes D, Beyerlein A, Katz K, Hoelscher G, Nennstiel U, Liebl B, Überla K, Von Kries R
Journal article
The complex regulatory role of cytomegalovirus nuclear egress protein pul50 in the production of infectious virus (2021)
Häge S, Büscher N, Pakulska V, Hahn F, Adrait A, Krauter S, Borst EM, et al.
Journal article
Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children (2021)
Laub O, Leipold G, Toncheva AA, Peterhoff D, Einhauser S, Neckermann P, Borchers N, et al.
Journal article
IMU-838, a small molecule DHODH inhibitor in phase II clinical trial for multiple sclerosis, shows potent Anti-EBV activity in cell-culture-based systems: Potential additional benefits in multiple sclerosis treatment (2021)
Marschall M, Peelen E, Müller R, Wangen C, Wagner S, Muehler A, Groeppel M, et al.
Conference contribution
Spectrum bias and individual strengths of SARS-CoV-2 serological tests–A population-based evaluation (2021)
Einhauser S, Peterhoff D, Niller HH, Beileke S, Günther F, Steininger P, Burkhardt R, et al.
Journal article
Reactogenicity correlates only weakly with humoral immunogenicity after COVID-19 vaccination with BNT162b2 mRNA (Comirnaty®) (2021)
Held J, Esse J, Tascilar K, Steininger P, Schober K, Irrgang P, Alsalameh R, et al.
Journal article
Cloning of a passage-free SARS-CoV-2 genome and mutagenesis using red recombination (2021)
Herrmann A, Jungnickl D, Cordsmeier A, Peter AS, Überla K, Enßer A
Journal article
‹
1
...
7
8
9
10
11
...
40
›